Skin cancer in Europe today and challenges for tomorrow

Lieve Brochez,Beate Volkmer,Isabelle Hoorens,Claus Garbe,Martin Röcken,Joachim Schüz,David C. Whiteman,Philippe Autier,Rüdiger Greinert,Brigitta Boonen
DOI: https://doi.org/10.1111/jdv.20368
2024-10-10
Journal of the European Academy of Dermatology and Venereology
Abstract:Skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer. One in every three cancers diagnosed is a skin cancer. Europe has the global lead in the number of UV‐attributable cancer cases with the highest number of melanoma cases worldwide and the second highest number of keratinocyte cancers (KC). Further increases are expected in Europe for the coming decades. Projected increases are highest for KC with increases in incidence around 40% and increases in mortality around 50%, with KC mortality in males approximating melanoma mortality in females. The two main drivers for this skin cancer epidemic are ageing of the population but especially UV exposure. In conclusion, skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer.
dermatology
What problem does this paper attempt to address?